U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07066865) titled 'Evaluation of the Safety and Effectiveness of omniLenz in Patient With Ocular Graft vs Host Disease' on June 19.
Brief Summary: A case series of patients presented with graft versus host disease with ocular involvement . The study recruited a total of 3 patients who were referred to cornea clinic of Farwaniya Hospital, Kuwait between April 2022 and April 2024. All cases presented with severe dryness, spks and corneal epithelial defect not responding to other measures of treatment. An OmniLenz was applied for each patient for one week. Primary outcome measures included healing of the corneal resistant epithelial defect, secondary out...